Skip to main
NTRA

Natera (NTRA) Stock Forecast & Price Target

Natera (NTRA) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 37%
Buy 53%
Hold 11%
Sell 0%
Strong Sell 0%

Bulls say

Natera is projected to continue its strong revenue growth, driven by its innovative products and expanding market opportunities. The company's focus on diversification and securing Medicare coverage positions them well for future success. With a solid track record of beating expectations, Natera has the potential for considerable growth in the coming years.

Bears say

Natera is a company with strong growth potential, driven by its innovative and market-leading products in NIPT, carrier screening, and minimal residual disease testing for cancer. However, there are concerns surrounding its high R&D expenses and the possibility of not meeting investor expectations for revenue growth in its Signatera MRD unit, which could negatively impact the stock. Additionally, while the company has raised its 2026 revenue guidance, it is still operating at a loss and has a history of negative earnings per share.

Natera (NTRA) has been analyzed by 19 analysts, with a consensus rating of Buy. 37% of analysts recommend a Strong Buy, 53% recommend Buy, 11% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of Natera and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Natera (NTRA) Forecast

Analysts have given Natera (NTRA) a Buy based on their latest research and market trends.

According to 19 analysts, Natera (NTRA) has a Buy consensus rating as of Sep 9, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $320.50, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $320.50, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Natera (NTRA)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.